---
category: news
title: "Velan Capital Agrees to Support Merger of Lantheus and Progenics"
excerpt: "About Progenics Progenics is an oncology company focused on the development and commercialization of innovative targeted medicines and artificial intelligence to find ... who require systemic anticancer therapy; and oral and subcutaneous formulations of RELISTORÂ® (methylnaltrexone bromide) for the treatment of opioid-induced constipation ..."
publishedDateTime: 2020-04-14T13:00:00Z
webUrl: "https://www.businesswire.com/news/home/20200414005506/en/Velan-Capital-Agrees-Support-Merger-Lantheus-Progenics"
type: article
quality: 4
heat: 4
published: false

provider:
  name: Business Wire
  domain: businesswire.com

topics:
  - AI in Healthcare
  - AI

secured: "CJIxRhzGBTHYAAoiepmkrCeKZ48/ulvO6IviZ2DiCC4VuVuQJ5dUpZCqsolJMmfz5if73h8rhtfE+c1Nk9M1zVaYAnOb5fEXAISsyIeptcE4e1RuzBI1yofDnjucwVfwtDYKcwgrI3rbATj1qsTpGxx/8IxZ8U4T/2AsVOyFX8wMn27B8mQkHfZv9do+eJ8/PXtcv/EBLlV7UxOEicvNPxe8IbFJ90osMQVwmxNM5EWdGOyBI9joqS89CgUyZOwLKqPfYQZ5lJV3BF1eHs2shOeZgisCqb1JCF8woC9P+Aq7Q4yIg5rGR6C6hkUYY8Y014dsT7dTc6b8D7ru04ApItqjz4ZMXkVHc6S/0HM00ZT9gA1VCmZxZNv2otNVz0FdqDfZbzCHl460HLfrjhr9e1RM1Iu8kmsyg2Zsv0NtA9/RgJHM4EvtSoHwxIEGjmihNxq76ItbwjIDZS2y/hAxOrPz7MWm/4aXQbCRE+6HB+g=;Ft++RRabhnO1DmdIhln8og=="
---

